American Well Corporation (NYSE:AMWL) Receives $9.17 Average PT from Analysts

Key Points

• American Well Corporation has a consensus rating of "Hold" from seven research firms, with six analysts recommending a hold and one a buy.
• The company's stock price target has been adjusted by several firms, with UBS lowering it from $12.00 to $9.00 and Wells Fargo from $15.00 to $12.00.
• American Well reported a quarterly revenue of $70.90 million, exceeding analyst expectations, while posting an EPS of (-$1.24), which was better than the anticipated (-$1.84).

Shares of American Well Corporation (NYSE:AMWL - Get Free Report) have been assigned an average recommendation of "Hold" from the seven research firms that are covering the company, Marketbeat reports. Six equities research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $9.1667.

Several research analysts recently issued reports on AMWL shares. Piper Sandler reissued a "neutral" rating and set a $8.00 price target (down from $10.00) on shares of American Well in a report on Friday, May 23rd. UBS Group reduced their target price on American Well from $12.00 to $9.00 and set a "neutral" rating on the stock in a research note on Thursday, May 8th. Finally, Wells Fargo & Company decreased their target price on shares of American Well from $15.00 to $12.00 and set an "overweight" rating on the stock in a research report on Thursday, August 7th.

American Well Trading Down 3.8%

NYSE:AMWL traded down $0.27 during trading hours on Tuesday, hitting $6.70. The company had a trading volume of 111,657 shares, compared to its average volume of 58,971. The company has a 50-day moving average of $7.75 and a 200 day moving average of $7.75. American Well has a 1 year low of $6.09 and a 1 year high of $12.95. The company has a market cap of $108.14 million, a P/E ratio of -0.83 and a beta of 1.27.

American Well (NYSE:AMWL - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported ($1.24) earnings per share for the quarter, beating the consensus estimate of ($1.84) by $0.60. American Well had a negative return on equity of 41.99% and a negative net margin of 46.15%.The company had revenue of $70.90 million during the quarter, compared to the consensus estimate of $63.87 million. American Well has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, analysts forecast that American Well will post -9.34 earnings per share for the current year.

Insider Buying and Selling

In other news, insider Phyllis Gotlib sold 4,958 shares of the firm's stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $8.63, for a total transaction of $42,787.54. Following the completion of the sale, the insider directly owned 136,891 shares in the company, valued at $1,181,369.33. This trade represents a 3.50% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Deborah C. Jackson sold 4,531 shares of American Well stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $7.10, for a total transaction of $32,170.10. Following the completion of the sale, the director owned 48,194 shares of the company's stock, valued at approximately $342,177.40. This trade represents a 8.59% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 9,820 shares of company stock valued at $77,814. Corporate insiders own 11.82% of the company's stock.

Institutional Trading of American Well

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Headlands Technologies LLC bought a new position in American Well in the 2nd quarter valued at about $39,000. Engineers Gate Manager LP acquired a new position in American Well in the 2nd quarter worth about $101,000. Norges Bank bought a new position in American Well during the second quarter valued at about $250,000. JPMorgan Chase & Co. boosted its holdings in shares of American Well by 16.5% during the 2nd quarter. JPMorgan Chase & Co. now owns 14,720 shares of the company's stock worth $131,000 after buying an additional 2,081 shares during the period. Finally, Senvest Management LLC increased its position in American Well by 0.3% in the 2nd quarter. Senvest Management LLC now owns 1,312,852 shares of the company's stock worth $11,671,000 after buying an additional 4,497 shares during the period. 56.05% of the stock is currently owned by institutional investors and hedge funds.

About American Well

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.